2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Single Center Experience in Ex Vivo Hilar Renal Artery Aneurysm Repair and Autotransplantation

A. Chang¹, K. Cederquist¹, P. Abt¹, G. Wang², B. Jackson², A. Naji¹
Single Center Experience on SARS-CoV-2 Testing of Symptomatic and Asymptomatic Pediatric Kidney Transplant Recipients

H. Pizzo¹, P. R. Soni², S. Nadipuram², J. Garrison¹, D. Puliyanda¹
Single Day Centralized Approach in Kidney Transplant Workup – Lessons Learned from 2 Centers

A. Vijay, N. Langford, K. Atiemo, S. Giusti, M. Killackey, A. Paramesh, H. Jeon
Single Incision Simultaneous Liver Kidney Transplantation: Outcomes and Feasibility

D. Imai, Y. Sambommatsu, A. Khan, S. Lee, A. Sharma, V. Kumaran, D. Bruno, A. Cotterell, C. Bhati, M. F. Levy
Single-cell Rna Sequencing of Latent Murine Cytomegalovirus Infected Lung Transplants

L. A. VanOsdol¹, S. Han¹, M. Kandpul², J. J. Wang¹, L. Qiu³, Z. J. Zhang¹
Single-Cell RNA-seq Identifies Intra-Graft Population Heterogeneity in Acute Heart Allograft Rejection in the Mouse

C. Wu¹, Y. Tang¹, X. Shi¹, X. He¹, X. Li²
Single-Dose Basiliximab Induction Therapy in Low-Immunologic Risk Kidney Transplant Recipients

A. Hutchins, J. Schoen, J. S. McMullen
Sirolimus (srl) versus Everolimus (evr) versus Mycophenolate (mpa) in Kidney Transplant Recipients Receiving Anti-thymocyte Globulin Induction (r-atg), Tacrolimus (tac), and Prednisone

H. Tedesco Silva Junior, C. Felipe, L. Viana, M. Cristelli, N. Tenorio, V. Lima, V. Azevedo, K. Ficher, J. Rezende, R. Foresto, M. Nakamura, Y. Dreige, J. Taddeo, C. Zito, J. Medina
Sodium Zirconium Cyclosilicate Use in Kidney Transplant Recipients

K. J. Swanson, F. Aziz, S. Parajuli, M. Mohamed, D. A. Mandelbrot, A. Djamali, N. Garg
Solid Organ Transplant Recipient Attitudes Towards a SARS-CoV-2 Vaccine

M. Ou¹, B. Boyarsky¹, L. Zeiser¹, T. Chiang¹, J. Ruddy¹, S. Rasmussen¹, J. Martin², J. Russell², C. Durand¹, R. Avery¹, W. Werbel¹, M. Cooper³, A. Massie¹, D. Segev¹, J. Garonzik-Wang¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z